Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 21, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and Ordinary Share ADRs, rather than a comprehensive financial performance report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on shareholding changes within employee benefit plans and trusts.
Material Changes
The following changes in directors' interests were reported:
- US Retirement Savings Plan: A re-valuation on February 17, 2005, increased the notional allocation of Ordinary Share ADRs from 18,374,705 to 18,458,392 at an average price of $46.59. Directors Dr. J.P. Garnier and Dr. T. Yamada are potentially interested in these shares.
- Employee Trust Transfers: On February 18, 2005, the GSK Trust transferred 20,076 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. Directors Dr. J-P Garnier, Dr. T Yamada, and Mr. J D Coombe are potentially interested in these shares.
- Share Sales and Transfers: On February 18, 2005, 262 Ordinary shares were sold on behalf of a participant in the SmithKline Beecham Bonus Investment Plan at £12.402 per share. Additionally, 855 Ordinary shares were transferred from the Trust to a participant. Director John Coombe is potentially interested in these shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a routine disclosure of director shareholding movements.
Investor Verification Checklist
- Verify the total number of shares held by directors Dr. J.P. Garnier, Dr. T. Yamada, and Mr. J.D. Coombe across all employee benefit plans.
- Confirm the impact of the US Retirement Savings Plan re-valuation on the notional ADR holdings.
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 and Bonus Investment Plan regarding director eligibility.